Home › Drug Codes › J Codes › J3032 · VYEPTI
Updated July 1st, 2026

VYEPTI J Code: J3032

Injection, eptinezumab-jjmr, 1 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J3032, effective October 1, 2026: $21.243 per HCPCS billing unit, up 0.7% from $21.101. From CMS's final file.

?
Medicare Payment Limit ?
$21.101
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$21.101
/ HCPCS billing unit · APC 9357
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, eptinezumab-jjmr, 1 mg
HCPCS Added Date October 1, 2020
Manufacturer Lundbeck Pharmaceticals
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection

About VYEPTI

Vyepti is a medication aligned to the HCPCS J Code: J3032 for billing, pricing, and reimbursement purposes in the United States. Classified under Neurology, it is administered via the intravenous route and manufactured by Lundbeck Pharmaceticals.

According to CMS Drug Use Information: This medication is used to help prevent migraine. This medication may work by changing the amounts of certain natural substances in the brain. Eptinezumab belongs to a class of drugs known as monoclonal antibodies. Preventing frequent migraine attacks can help improve your ability to concentrate and do your usual tasks.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
67386-0130-51 Vyepti Lundbeck Pharmaceuticals LLC 100 100 MG / 1 ML
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

VYEPTI Pricing & Reimbursement

J3032 Private Payer Reimbursement
$20.38 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

VYEPTI Claims Performance

Claims from Jan 2026 – Aug 2026
Claim Denial Rate 14.53%
Avg. Days to File 6.0days
Avg. Days to Pay 20.3days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J3032 claims analytics on FocalPoint →
OnPoint Oncology

VYEPTI CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Vyepti (J3032) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

VYEPTI Medically Unlikely Edits (MUE)

The most billing units of J3032 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient
300 units / day
= 300 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

VYEPTI Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Migraine
Drug Class
Calcitonin Gene-related Peptide Antagonist [EPC]Calcitonin Gene-related Peptide Antagonists [MoA]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available Vyepti billing and coding guide?
Billing and coding information for VYEPTI can be found through Lundbeck. Visit Here →
Are there any available Vyepti patient assistance programs?
VYEPTI patient assistance information can be found through Lundbeck. Visit Here →
Where can I find Vyepti prescribing information?
VYEPTI prescribing information can be found at the link below: Visit Here →
Where can I find Vyepti side effect information?
Information regarding VYEPTI's side effects can be found at MedlinePlus Visit Here →
Does billing VYEPTI require JZ/JW wastage modifiers?
CMS has identified VYEPTI(J3032) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to VYEPTI.

J3030SUMATRIPTAN SUCCINATEInjection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)Multiple ManufacturersAdded January 1, 1986J3031AJOVY SYRINGEInjection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)TevaAdded October 1, 2019C9157QALSODYInjection, tofersen, 1 mgBiogenAdded October 1, 2023C9160DAXXIFYInjection, daxibotulinumtoxina-lanm, 1 unitRevance TherapeuticsAdded January 1, 2024C9254VimpatInjection, lacosamide, 1 mgUCB PharmaAdded January 1, 2010J0172AduhelmInjection, aducanumab-avwa, 2 mgBiogenAdded January 1, 2022J0174LEQEMBILecanemab-irmb, for intravenous injection, 1 mgEisaiAdded July 6, 2023J0175KISUNLAInjection, donanemab-azbt, 2 mgEli LillyAdded July 2, 2024J0190BIPERIDEN LACTATEInjection, biperiden lactate, per 5 mgAdded January 1, 1982J0202LEMTRADAInjection, alemtuzumab, 1 mgGenzymeAdded January 1, 2016